An agonist of receptors, adrenergic alpha-2 that is used in veterinary medicine for its analgesic and sedative properties. It is the racemate of dexmedetomidine.
Administered intravenously, dexmedetomidine is indicated for the sedation of initially intubated and mechanically ventilated patients during treatment in intensive care settings, and for the sedation of non-intubated patients prior to and/or during surgery and other procedures. It is also available as a buccally- or sublingually-administered dissolvable film for the acute treatment of agitation associated with schizophrenia or bipolar I or II disorder.
the Affiliated Hospital of Yangzhou University, Yangzhou, Jiangsu, China
Union Hospital, Wuhan, Hubei, China
Univeristy of Thessaly, Larissa, Thessaly, Greece
Clinique Saint-Pierre, Ottignies, Belgium
CUB Erasme Hospital ULB, Bruxelles, Belgium
Civil hospital Marie Curie, Charleroi, Belgium
China, Shandong Qianfoshan Hospital, Jinan, Shandong, China
Zhongshan Hospital, Fudan University, Shanghai, Shanghai, China
Mayo Clinic in Rochester, Rochester, Minnesota, United States
Faculty of Medicine, Tanta, Algharbia Governate, Egypt
The second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, China
Faculty of Medicine, Assiut University, Assiut, Egypt
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.